News for BioSpecifics Technologies Corp. (BSTC)

Published at

Apr 19, 2022 5:00 PM

by globenewswire.com

mixed

mixed

Hormone Replacement Therapy Market Is Set to Expand at a CAGR Of 5.7% To reach US$ 27.8 Billion By The Year 2032: FMI

Companies Profiled in Hormone Replacement Therapy Market are Eli Lilly and Company, Pfizer, Inc., AbbVie, Inc., Novo Nordisk A/S, Merck KGaA, Mylan N.V.,...

ABBV34.SA ABBV.MX ABBV.BA ABBV 4AB.DE SUNPHARMA-BL.NS PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE NVSN.MX NVSEF NVSD.BA NVS NVON.MX NVO NOVOBN.MX NOVN.SW NOVC.DE NOVA.DE NONOF N1VS34.SA MYL LLY.MX LLY.DE LLY.BA LLY LILY34.SA ENDP BSTC 0Y5F.L 0TDD.L 0Q1G.L 0K9E.L

Read more →
Published at

Sep 9, 2021 2:00 AM

by vcaonline.com

neutral

neutral

Venture Capital Access Online

iECURE Launches With $50 Million Series A Financing to Develop In Vivo Gene Insertion Approaches for Devastating Diseases - Financing led by Versant Ventures an...

BSTC

Read more →
Published at

May 28, 2021 1:00 PM

by marketscreener.com

mixed

mixed

Werewolf Therapeutics Appoints Mike Sherman to its Board of Directors

CAMBRIDGE, Mass., May 28, 2021 -- Werewolf Therapeutics, Inc. , an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to... | May 28, 2021

HOWL CMRX BSX.MX BSX-PA BSX BSTC B1SX34.SA 0HOY.L

Read more →